Latest

Cellworks: Predictions of Overall Survival And Progression-Free Survival For Therapeutic Interventions In Glioblastoma Multiforme

Cellworks Singula Therapy Response Index (TRI) Predicts Clinical Outcomes For Esophageal Adenocarcinoma: MyCare-004

Coherus and Junshi Biosciences Announce PD-1 Inhibitor Toripalimab Granted Orphan Drug Designation for Small Cell Lung Cancer

OncoResponse Mines PD-1 Therapy “Elite Responders” For IO Breakthroughs

FDA Authorizes Merck’s Covid-19 Pill for At-Home Treatment

Wall Street Journal: Behind a New Pill to Treat Covid: A Husband-and-Wife Team and a Hunch

Coherus Announces U.S. FDA Approval of YUSIMRY™ (adalimumab-aqvh)

Coherus and Junshi Biosciences Announce Positive Interim Overall Survival Results of CHOICE-01, a Phase 3 Clinical Trial Evaluatin